Tanshindiol B
Tanshindiol B possesses a unique anti-cancer activity whose mechanism involves the inhibition of EZH2 activity and would provide chemically valuable information for designing a new class of potent EZH2 inhibitors. It also possesses the anti-angiogenic activity, so it can be a promising candidate for angiogenesis inhibitors.
Product Specifications
CAS Number
97465-70-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
312.32
Molecular Formula
C18H16O5
Notes
Research use only, not for human use.
Receptor
Histone Methyltransferase
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
F6070-01 5 µg
Fractalkine, Recombinant, Human (CX3CL1) discontinued
Sign In for Pricing
View Details F6070-02 20 µg
Fractalkine, Recombinant, Human (CX3CL1) discontinued
Sign In for Pricing
View Details 
MBS6360947-01 0.2 mL
UBP17, CT (USP17, Ubiquitin carboxyl-terminal hydrolase 17, Deubiquitinating enzyme 17, Ubiquitin thioesterase 17, Ubiquitin-specific-processing protease 17) (PE)
Sign In for Pricing
View Details MBS6360947-02 5x 0.2 mL
UBP17, CT (USP17, Ubiquitin carboxyl-terminal hydrolase 17, Deubiquitinating enzyme 17, Ubiquitin thioesterase 17, Ubiquitin-specific-processing protease 17) (PE)
Sign In for Pricing
View Details MBS2150541-01 0.1 mL
APC_Cy7-Linked Monoclonal Antibody to Cluster of Differentiation 79B (CD79B)
Sign In for Pricing
View Details